Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Neuromolecular Medicine|May 6, 2016
Nutraceuticals in Parkinson's DiseaseLiting Hang, Adeline Henry Basil, Kah-Leong LimAnnals of the New York Academy of Sciences|June 30, 2015
Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuroprotectionLiting Hang, John Thundyil, Kah-Leong LimFrontiers in Aging Neuroscience|January 22, 2016
Parkin Regulation and Neurodegenerative DisordersCheng-Wu Zhang, Liting Hang, Tso-Pang Yao, et al.Neuromolecular Medicine|November 10, 2018
AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 ExpressionLiting Hang, John Thundyil, Geraldine W Y Goh, et al.Neuromolecular Medicine|October 31, 2019
Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced NeurotoxicityJoan Poh Ling Sim, Wang Ziyin, Adeline Henry Basil, et al.Neuromolecular Medicine|April 28, 2022
Prostaglandin A2 Interacts with Nurr1 and Ameliorates Behavioral Deficits in Parkinson's Disease Fly ModelSreekanth Rajan, Hui Ting Toh, Hong Ye, et al.Expert Opinion on Drug Discovery|July 25, 2012
Non-mammalian animal models of Parkinson's disease for drug discoveryKah-Leong LimExpert Review of Proteomics|December 11, 2007
Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversiesKah-Leong LimPlos One|September 12, 2013
Proteasome inhibition promotes Parkin-Ubc13 interaction and lysine 63-linked ubiquitinationGrace G Y Lim, Katherine C M Chew, Xiao-Hui Ng, et al.Pageof 15